Ozmat MD 10 Tablet contains Olanzapine 10mg, an atypical antipsychotic agent primarily indicated for the treatment of schizophrenia and bipolar disorder. Olanzapine exerts its therapeutic effects by modulating the activity of various neurotransmitter receptors in the brain, including dopamine and serotonin receptors, which are implicated in the pathophysiology of psychotic and mood disorders. Ozmat MD 10 Tablet is effective in reducing symptoms such as hallucinations, delusions, disorganized thinking, and mood swings, thereby improving overall patient functioning and quality of life. It is also used for the maintenance treatment of bipolar disorder to prevent recurrence of manic or depressive episodes. The tablet should be administered orally, with dosage individualized based on clinical response and tolerability. Common adverse effects may include sedation, weight gain, increased appetite, and metabolic changes such as hyperglycemia and dyslipidemia; therefore, regular monitoring of metabolic parameters is recommended during therapy. Caution is advised in patients with a history of cardiovascular disease, diabetes, or seizures. Ozmat MD 10 Tablet should be used under strict medical supervision, with gradual dose adjustments to minimize side effects and optimize therapeutic outcomes. It is contraindicated in patients with known hypersensitivity to Olanzapine or any tablet excipients.